|Articles|September 2, 2020
AstraZeneca COVID-19 vaccine to US Phase 3 trial
Author(s)Lindsey Carr, Editor
According a press release and a recent article from Drug Topics, AstraZeneca’s investigational vaccine candidate AZD12222 expanded into a phase 3 clinical trial.
Advertisement
The trial is funded by the Biomedical Advanced Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID).
Up to 30,000 adults aged 18 years or older will be enrolled to assess the safety and immunogenicity of AZD1222, which was co-invented by the University of Oxford and Vaccitech.
For more information, read the full article from
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA: Levonorgestrel/ethinyl estradiol birth control patch sees update to labeled strength
2
Spotlighting menopause and mental health with Jessica Gaulton, MD, MPH
3
Using a self-collected vaginal fluid test for endometrial cancer detection
4
Shared decision-making key to non-hormonal VMS and sleep management in menopause
5